Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Ventricular Repolarization Markers in Heart Failure with Reduced Ejection Fraction.
Emre YılmazErtan AydınSencer ÇamcıDevrim KurtErcan AydınPublished in: Cardiovascular drugs and therapy (2022)
The addition of SGLT2 inhibitors to optimal medical therapy in HFrEF patients positively changes VRM (QT, QTc, QTd, Tp-e, and Tp-e/QTc).